Plasmodium falciparum M1 alanyl-aminopeptidase N inhibitors (Leidos Biomedical Research)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePlasmodium falciparum M1 alanyl-aminopeptidase N inhibitors (Leidos Biomedical Research)
Drug Alias NameLSC-JHJ-III-126-6LSC-JHJ-III-130-3
ClassificationSmall molecules
Mechanisms of ActionAminopeptidase N inhibitors
TargetsAminopeptidase N
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeidos Biomedical Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A